Pharmaceutical

EC grants approval to Merck’s Keytruda for gastric cancer

The EC has granted approval for Merck’s Keytruda regimen for gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Aug 30, 2023 - 20:00
EC grants approval to Merck’s Keytruda for gastric cancer
The EC has granted approval for Merck’s Keytruda regimen for gastric or gastroesophageal junction (GEJ) adenocarcinoma.
Read the original article

Tags:

Previous Article

Biostax and Immgenuity to expedite HIV immunotherapies development

Next Article

Alvotech and Bioventure gain approval for Humira biosimilar in Egypt

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Senators push IRS to launch nonprofit hospital probe

Senators push IRS to launch nonprofit hospital probe

Aug 9, 2023

LyGenesis and Imagine Pharma partner for type 1 diabetes therapies development

LyGenesis and Imagine Pharma partner for type 1 diabete...

Apr 12, 2023

MBX-1416 by MBX Biosciences Inc for Hypoglycemia: Likel...

Nov 4, 2023